

HY-P99344 · 1 mg
MedChemExpress · Cat: HY-P99344
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bamlanivimab.html
Description
Bamlanivimab Anti-Human SARS-CoV-2 is the first COVID-19 monoclonal antibody mAb to be granted Emergency Use Authorization EUA in November 2020 by the U.S. Food and agent Administration FDA . However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab.







